Evidence That Stocks are More Overvalued than Ever
GSV Capital a Great Risk-Reward Opportunity With Improving IPO Market
Obamacare Will Still Exist in 2018...But in What Form?
Liberty One (LBY: CA) Options Pocitos Project from Millennial Lithium
Electric and Autonomous Vehicles: Coming Sooner Than You Thought
Dr. Daniel Teper, CEO of Immune Pharmaceuticals, Inc. (NASDAQ: IMNP) sits down with Equities.com's Sasha Salama to discuss the company's major milestones and catalysts.
You have to be logged in to leave a comment.
I'm sorry, but in order to complete what you're trying to do, you must be logged in.
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).